New blood test could sharpen monitoring for rare liver disease
NCT ID NCT05783687
Summary
This study tested a new, more precise blood test to measure 'free' copper levels in people with Wilson's Disease. It involved 50 adult patients who had extra blood drawn during their regular doctor visits over about a year. The goal was to see if this new test provides better information to help doctors manage treatment compared to current standard tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health Orlando
Orlando, Florida, 32803, United States
-
John Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
New York Presbyterian Hospital-Columbia University Medical Centre
New York, New York, 10032, United States
-
Northwestern University Chicago (Hepatologist)
Chicago, Illinois, 60611, United States
-
UC Davis Midtown Ambulatory Care Centre
Sacramento, California, 95817, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Vanderbilt University Medical Centre
Nashville, Tennessee, 37212, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.